Correlation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patients
作者： K. Thriveni , Lakshmi Krishnamoorthy , Girija Ramaswamy
DOI: 10.1007/BF02912882
关键词:
摘要: Carcino Embryonic Antigen (CEA) and Cancer 15.3 (CA15.3) are the most common tumor markers in breast cancer patients. Measurement of circulating is a non-invasive quantitative method. Serum levels CEA CA were studied female patients prior to treatment. To evaluate utility these markers, 207 Breast carcinoma belonging all stages considered. Healthy age matched 75 individuals formed control group. The serum analyzed by Enzyme Linked Immunosorbent Assay (ELISA). Results taken compared with stages, size, node grade. significant study parameters whereas showed no changes any parameters. correlation (24.8%) advanced larger sizes, did not show
springer.com
sci-hub.se 参考文章(21)
Carlo Tondini, Daniel F. Hayes, Donald W. Kufe, Circulating Tumor Markers in Breast Cancer Hematology/Oncology Clinics of North America. ,vol. 3, pp. 653- 674 ,(1989) , 10.1016/S0889-8588(18)30525-2
E.C. Coveney, J.G. Geraghty, F. Sherry, E.W. McDermott, J.J. Fennelly, N.J. O'higgins, M.J. Duffy, The clinical value of CEA and CA 15-3 in breast cancer management. International Journal of Biological Markers. ,vol. 10, pp. 35- 41 ,(1995) , 10.1177/172460089501000107
JF Robertson, D Pearson, MR Price, C Selby, RW Blamey, A Howell, Objective measurement of therapeutic response in breast cancer using tumour markers. British Journal of Cancer. ,vol. 64, pp. 757- 763 ,(1991) , 10.1038/BJC.1991.394
George Pentheroudakis, Vassiliki Malamou-Mitsi, Evangelos Briasoulis, Konstantina Damala, Amalia Vassou, George Vartholomatos, Nikos Kolaitis, Nikolas Pavlidis, The neutrophil, not the tumor Cancer. ,vol. 101, pp. 1767- 1775 ,(2004) , 10.1002/CNCR.20581
Lawrence E Harrison, Jose G Guillem, Philip Paty, Alfred M Cohen, Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients Journal of The American College of Surgeons. ,vol. 185, pp. 55- 59 ,(1997) , 10.1016/S1072-7515(97)00012-4
Phil Gold, Samuel O. Freedman, DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES Journal of Experimental Medicine. ,vol. 121, pp. 439- 462 ,(1965) , 10.1084/JEM.121.3.439
M.R. Price, P.D. Rye, E. Petrakou, A. Murray, K. Brady, S. Imai, S. Haga, Y. Kiyozuka, D. Schol, M.F.A. Meulenbroek, F.G.M. Snijdewint, S. von Mensdorff-Pouilly, R.A. Verstraeten, Kenemans NIL, A. Blockzjil, Nilsson NIL, O. Nilsson, Reddish NIL, M.R. Suresh, Koganty NIL, S. Fortier, Baronic NIL, A. Berg, M.B. Longenecker, Hilkens NIL, M. Boer, Karanikas NIL, I.F.C. McKenzie, Galanina NIL, L.A. Simeoni, A.G. Ter-Grigoryan, I.M. Belyanchikov, N.V. Bovin, Y. Cao, U. Karsten, J. Dai, W.J. Allard, G. Davis, K.K. Yeung, F.-G. Hanisch, K.O. Lloyd, V. Kudryashov, R. Sikut, A. Sikut, K. Zhang, D. Baeckström, G.C. Hansson, C.A. Reis, H. Hassan, E.P. Bennett, H. Claussen, L. Norum, T. Varaas, B. Kierulf, K. Nustad, P. Ciborowski, W.M. Konitzki, J. Magarian- Blander, O.J. Finn, J. Hilgers, Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin Tumor Biology. ,vol. 19, pp. 1- 20 ,(1998) , 10.1159/000056500
Nicola Pietra, Leopoldo Sarli, Renato Costi, Choua Ouchemi, Mario Grattarola, Anacleto Peracchia, Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Diseases of The Colon & Rectum. ,vol. 41, pp. 1127- 1133 ,(1998) , 10.1007/BF02239434
M. Busetto, L. Vianello, R. Franceschi, M. Bolzan, CA 15-3 Value and Neoplastic Disease Predictivity in the Follow-Up for Breast Cancer Tumor Biology. ,vol. 16, pp. 243- 253 ,(1995) , 10.1159/000217941
R Nalini, CR Wilma Delphine Silvia, Purnima M Makhija, Sheila Uthappa, None, Usefulness of serum CA 15.3 and histopathological prognostic indices in breast cancer Indian Journal of Clinical Biochemistry. ,vol. 20, pp. 165- 168 ,(2005) , 10.1007/BF02893065